Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples
Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Jun 14, 2018
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Patients detected positive for one of the three (Sexually Transmitted Infection)STIs (Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma genitalium) on one site will be re-sampled twice at each of the three sites (pharynx, rectum, urine) before receiving antibiotics. Then, a real-time multiplex PCR will be performed on the pooled sample (merging pharyngeal, anorectal and urinary samples) versus on each of the three samples separately (i.e. standard of care) to compare both sensitivities.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patient having provided a written consent;
- • Patient age \> 18 years;
- • Man who have sex with men tested positive for one the three STIs : Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma genitalium
- • Covered by health insurance
- Exclusion Criteria:
- • Being under tutorship
- • Being deprived of liberty
- • Patient who received antibiotic treatment prior to study inclusion and re-sampling
About Centre Hospitalier Régional D'orléans
The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Poitiers, , France
Niort, , France
Orléans, , France
Quimper, , France
Patients applied
Trial Officials
Thierry PRAZUCK, Dr
Principal Investigator
CHR d'Orléans
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials